These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15925115)

  • 21. Paraoxonase gene polymorphism and vitamin levels during pregnancy: Relationship with maternal oxidative stress and neonatal birthweights.
    Min J; Park H; Park B; Kim YJ; Park J; Lee H; Ha E; Park E; Hong YC
    Reprod Toxicol; 2006 Oct; 22(3):418-24. PubMed ID: 16515855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life and cholinesterase inhibitors: a qualitative study of patients with Alzheimer's disease and their carers.
    Smith B; Chur-Hansen A; Neale A; Symon J
    Australas Psychiatry; 2008 Dec; 16(6):433-7. PubMed ID: 18777227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging treatment effects in Alzheimer's disease.
    Venneri A
    Magn Reson Imaging; 2007 Jul; 25(6):953-68. PubMed ID: 17446028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease.
    Connelly PJ; Prentice NP; Fowler KG
    Int J Geriatr Psychiatry; 2005 Jul; 20(7):623-8. PubMed ID: 16021654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association study of the paraoxonase 1 gene with the risk of developing Alzheimer's disease.
    Chapuis J; Boscher M; Bensemain F; Cottel D; Amouyel P; Lambert JC
    Neurobiol Aging; 2009 Jan; 30(1):152-6. PubMed ID: 17624629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verbal repetition in patients with Alzheimer's disease who receive donepezil.
    Asp E; Cloutier F; Fay S; Cook C; Robertson ML; Fisk J; Dei DW; Rockwood K
    Int J Geriatr Psychiatry; 2006 May; 21(5):426-31. PubMed ID: 16676290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.
    López-Pousa S; Olmo JG; Franch JV; Estrada AT; Cors OS; Nierga IP; Gelada-Batlle E
    Age Ageing; 2006 Jul; 35(4):365-71. PubMed ID: 16788079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project.
    Franchi C; Lucca U; Tettamanti M; Riva E; Fortino I; Bortolotti A; Merlino L; Pasina L; Nobili A
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):497-505. PubMed ID: 21432941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The usefulness of cube copying for evaluating treatment of Alzheimer's disease.
    Palmqvist S; Hansson O; Minthon L; Londos E
    Am J Alzheimers Dis Other Demen; 2008; 23(5):439-46. PubMed ID: 18955723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.
    Connelly PJ; Prentice NP; Cousland G; Bonham J
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):155-60. PubMed ID: 17600848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
    Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention.
    Regieli JJ; Jukema JW; Doevendans PA; Zwinderman AH; Kastelein JJ; Grobbee DE; van der Graaf Y
    J Am Coll Cardiol; 2009 Sep; 54(14):1238-45. PubMed ID: 19778663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cognitive effects of cholinesterase inhibitor treatment in every-day practice.
    Kapaki E; Paraskevas GP
    Curr Med Res Opin; 2005 Jun; 21(6):871-5. PubMed ID: 15969887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.
    Wang B; Zhou S; Yang Z; Xie YC; Wang J; Zhang P; Lv Z; Zheng C; Ma X
    J Neurol Sci; 2008 Jul; 270(1-2):148-51. PubMed ID: 18396294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The paraoxonase gene polymorphism in stroke patients and lipid profile.
    Shin BS; Oh SY; Kim YS; Kim KW
    Acta Neurol Scand; 2008 Apr; 117(4):237-43. PubMed ID: 17854416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease.
    Candore G; Balistreri CR; Grimaldi MP; Vasto S; Listì F; Chiappelli M; Licastro F; Lio D; Caruso C
    Ann N Y Acad Sci; 2006 Nov; 1089():472-86. PubMed ID: 17261790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
    Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
    Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study.
    Devine ME; Fonseca JA; Walker RW; Sikdar T; Stevens T; Walker Z
    Int J Geriatr Psychiatry; 2007 Nov; 22(11):1120-6. PubMed ID: 17457951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?
    Akçay YD; Sagin FG; Sendağ F; Oztekin K; Sozmen EY
    Maturitas; 2006 Feb; 53(3):325-32. PubMed ID: 16023312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.